FDA to require notice of additives in food supply for the first time

The U.S. Food and Drug Administration (FDA) announced on Monday that it will require companies to notify the agency before adding new substances to food products, marking the first time such a requirement has been implemented. Under the new policy, manufacturers must submit detailed information about how they determined a substance is “generally recognized as safe” (GRAS). This includes data supporting their claim that the additive poses no significant risk to human health. Companies already using GRAS substances will also be required to disclose how these additives are applied, with the information becoming publicly available in a centralized database managed by the Department of Health and Human Services (HHS). The policy aims to close a longstanding gap in regulatory oversight. For decades, food additives have entered the marketplace with minimal scrutiny, relying on industry self-assessment rather than independent evaluation. Advocates argue that this system has allowed thousands of untested chemicals into the food supply, leaving both regulators and consumers in the dark about potential health impacts. Vani Hari, known online as the FoodBabe, praised the initiative as a “major step forward,” emphasizing that transparency is essential for informed consumer choices. She noted that the new requirement would enable the FDA and researchers to better track which additives are commonly consumed and assess their safety over time. HHS Secretary Robert F. Kennedy Jr. has long criticized the GRAS process, calling it an outdated loophole that allows dangerous substances to bypass rigorous testing. His Make America Healthy Again (MAHA) movement has campaigned against the practice, arguing that it enables the proliferation of chemically laden foods. He has specifically targeted artificial dyes, such as red dye No. 3, which have been associated with adverse effects in animal studies. Although the Biden administration recently banned red dye No. 3, Kennedy continues to push for broader reforms. However, the new FDA proposal does not fully eliminate the GRAS exemption. Instead, it mandates disclosure, ensuring that the agency gains greater visibility into the composition of food products. FDA Acting Commissioner Kyle Diamantas emphasized during a press call that the proposed rule does not grant the FDA pre-market approval authority over new additives. Such power would require congressional action to amend the Food, Drug, and Cosmetic Act of 1938. Nevertheless, Diamantas described the policy as a “significant change” that enhances transparency and strengthens the FDA’s ability to monitor the food supply. The agency will conduct two reviews of each submitted GRAS application: a preliminary assessment within 45 days and a more thorough evaluation within 180 days. During this period, the FDA may request additional information or reject applications that fail to meet legal standards. Public health experts have generally welcomed the shift toward greater oversight. Jennifer Pomeranz, a public health lawyer and researcher, highlighted the importance of post-market monitoring, noting that without this requirement, the FDA would lack the tools to identify potentially harmful substances. She pointed out that many food companies do not voluntarily disclose GRAS ingredients, either on labels or to regulatory bodies. “Without this requirement, there is no method for the FDA to identify their existence,” she said. However, some critics remain skeptical. Former FDA Commissioner David Kessler argued that the policy fails to address the root causes of chronic diseases, such as excessive consumption of refined sugars and processed carbohydrates, which are prevalent in ultra-processed foods. Meanwhile, a separate trend has emerged in the realm of cosmetic procedures, with increasing numbers of individuals turning to self-administered treatments. Online platforms have facilitated the sale of restricted products, including botulinum toxins and dermal fillers, often sourced from overseas suppliers. Influencers and DIY beauty enthusiasts have embraced these practices, sharing tutorials and personal experiences with their audiences. While the FDA regulates these substances as prescription drugs, the ease of access and affordability have driven demand, particularly among those seeking alternatives to costly professional treatments. This growing subculture raises concerns about safety, as improper use of these products can lead to serious complications.